Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis

References

• Sartor RB. Mucosal immunology and mechanisms of gastrointestinal inflammation. In: Feldman M, Friedman LS, Sleisenger MH, , et al., Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. Volume I. 7th ed. Philadelphia: WB Saunders: 2002. pp 21–51.
   Google Scholar
• Liu Q, Wang Y, Wan MX, Zhang XW, Andersson G, Hedlund G, et al. Roquinimex inhibits dextran sodium sulfate-induced murine colitis. Inflamm Res 2003; 52: 64–8
   PubMed Web of Science ®Google Scholar
• El-Assal ON, Besner GE. HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. Gastroenterology 2005; 129: 609–25
   PubMed Web of Science ®Google Scholar
• Matsuura M, Okazaki K, Nishio A, Nakase H, Tamaki H, Uchida K, et al. Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis. Gastroenterology 2005; 128: 975–86
   PubMed Web of Science ®Google Scholar
• McCole DF, Rogler G, Varki N, Barrett KE. Epidermal growth factor partially restores colonic ion transport responses in mouse models of chronic colitis. Gastroenterology 2005; 129: 591–608
   PubMed Web of Science ®Google Scholar
• Sinha A, Nightingale J, West KP, Berlanga-Acosta J, Playford RJ. Epidermal growth factor enemas with oral mesalamine for mild to moderate left-sided ulcerative colitis or proctitis. N Engl J Med 2003; 349: 350–7
   PubMed Web of Science ®Google Scholar
• Marini M, Bamias G, Rivera-Nieves J, Moskaluk CA, Hoang SB, Ross WG, et al. TNF-α neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc Natl Acad Sci USA 2003; 100: 8366–71
   PubMed Web of Science ®Google Scholar
• Zeissig S, Bojarski C, Buergel N, Mankertz J, Zeitz M, Fromm M, et al. Down-regulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumor necrosis factor a antibody treatment. Gut 2004; 53: 1295–302
   PubMed Web of Science ®Google Scholar
• Korzenik JR, Dieckgraefe BK. An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease. Aliment Pharmacol Ther 2005; 21: 391–400
   PubMed Web of Science ®Google Scholar
• Dejaco C, Lichtenberger C, Miehsler W, Oberhuber G, Herbst F, Vogelsang H, et al. An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease. Digestion 2003; 68: 63–70
   PubMed Web of Science ®Google Scholar
• Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R, et al. Purification and biochemical characterization for human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci USA 1985; 82: 1526–30
   PubMed Web of Science ®Google Scholar
• Calhoun DA, Christensen RD. Human developmental biology of granulocyte colony-stimulating factor. Clin Perinatol 2000; 27: 559–76
   PubMed Web of Science ®Google Scholar
• Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175–81
   PubMed Web of Science ®Google Scholar
• Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H, et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 2005; 11: 305–11
   PubMed Web of Science ®Google Scholar
• Hou XW, Son J, Wang Y, Ru YX, Lian Q, Majiti W, et al. Granulocyte colony-stimulating factor reduces cardiomyocyte apoptosis and improves cardiac function in adriamycin-induced cardiomyopathy in rats. Cardiovasc Drugs Ther 2006; 20: 85–91
   PubMed Web of Science ®Google Scholar
• Solaroglu I, Tsubokawa T, Cahill J, Zhang JH. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience 2006; 143: 965–74
   PubMed Web of Science ®Google Scholar
• Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R, et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 2005; 115: 2083–98
   PubMed Web of Science ®Google Scholar
• Meuer K, Pitzer C, Teismann P, Kruger C, Goricke B, Laage R, et al. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. J Neurochem 2006; 97: 675–86
   PubMed Web of Science ®Google Scholar
• Zavala F, Masson A, Hadaya K, Ezihne S, Schneider E, Babin O, et al. Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice. J Immunol 1999; 163: 5125–32
   PubMed Web of Science ®Google Scholar
• Myrup B, Valerius NH, Mortensen PB. Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor. Gut 1998; 42: 127–30
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Ihara K, Matsumoto T, Tsutsumi Y, Nomura A, Ohga S, et al. Inflammatory bowel disease-like colitis in glycogen storage disease type 1b. Inflamm Bowel Dis 2001; 7: 128–32
   PubMed Web of Science ®Google Scholar
• Melis D, Parenti G, Della Casa R, Sibilio M, Berni Canani R, et al. Crohn's like ileo-colitis in patients affected by glycogen storage disease Ib: two years’ follow-up of patients with a wide spectrum of gastrointestinal signs. Acta Paediatr 2003; 92: 1415–21
   PubMed Web of Science ®Google Scholar
• Egi H, Hayamizu K, Yoshimitsu M, Shimamoto F, Oishi K, Ohmori I, et al. Regulation of T helper type-1 immunity in hapten-induced colitis by host pretreatment with granulocyte colony-stimulating factor. Cytokine 2003; 23: 23–30
   PubMed Web of Science ®Google Scholar
• Canpolat FE, Yurdakök M, Özsoy S, Haziroglu R, Korkmaz A. Protective effects of recombinant human granulocyte colony stimulating factor in a rat model of necrotizing enterocolitis. Pediatr Surg Int 2006; 22: 719–23
   PubMed Web of Science ®Google Scholar
• Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694–702
   PubMed Web of Science ®Google Scholar
• Miceli R, Hubert M, Santiago G, Yao DL, Coleman TA, Huddleston KA, et al. Efficacy of kerationcyte growth factor-2 in dextran sulfate sodium-induced murine colitis. J Pharm Exp Ther 1999; 290: 464–71
   PubMed Web of Science ®Google Scholar
• Williams KL, Fuller CR, Dieleman LA, DaCosta CM, Haldeman KM, Sartor RB, et al. Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology 2001; 120: 925–37
   PubMed Web of Science ®Google Scholar
• Obermeier F, Kojouharoff G, Hans W, Schölmerich J, Gross V, Falk W. Interferon-gamma (IFN-γ) and tumor necrosis factor (TNF) induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 1999; 116: 238–45
   PubMed Web of Science ®Google Scholar
• Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, Holland G, et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 1996; 98: 1010–20
   PubMed Web of Science ®Google Scholar
• Melgar S, Karlsson A, Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: Correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 2005; 288: 1328–38
   PubMed Web of Science ®Google Scholar
• Dieleman LA, Palmen MJHJ, Aoki H, Bloemena E, Pena AS, Meuwissen SGM, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998; 114: 385–91
   PubMed Web of Science ®Google Scholar
• Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextan sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994; 107: 1643–52
   PubMed Web of Science ®Google Scholar
• Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE, Buchler MW. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 2000; 62: 240–8
   PubMed Web of Science ®Google Scholar
• Panja A, Goldberg S, Eckmann L, Krishen P, Mayer L. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells. J Immunol 1998; 161: 3675–84
   PubMed Web of Science ®Google Scholar
• Deem RL, Shanahan F, Targan SR. Triggered human mucosal T cells release tumor necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells. Clin Exp Immunol 1991; 83: 79–84
   PubMed Web of Science ®Google Scholar
• Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007; 446: 557–61
   PubMed Web of Science ®Google Scholar
• Mashimo H, Wu DC, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996; 274: 262–5
   PubMed Web of Science ®Google Scholar
• Ni J, Chen SF, Hollander D. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes. Gut 1996; 39: 234–41
   PubMed Web of Science ®Google Scholar
• Sartor RB, Anderle SK, Rifai N, Goo DA, Cromartie WJ, Schwab JH. Protracted anemia associated with chronic, relapsing systemic inflammation induced by arthropathic peptidoglycan-polysaccharide polymers in rats. Infect Immun 1989; 57: 1177–85
   PubMed Web of Science ®Google Scholar
• Avalos BR. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 1996; 88: 761–77
   PubMed Web of Science ®Google Scholar
• Ramsay RG, Micallef SJ, Williams B, Lightowler S, Vincan E, Heath JK, et al. Colony-stimulating factor-1 promotes clonogenic growth of normal murine colonic crypt epithelia cells in vitro. J Interferon Cytokine Res 2004; 24: 416–27
   PubMed Web of Science ®Google Scholar
• Unal AE, Cevikel MH, Ozgun H, Tunger A. Effect of granulocyte-macrophage colony stimulating factor on bacterial translocation after experimental obstructive jaundice. Eur J Surg 2001; 167: 366–70
   PubMedGoogle Scholar
• Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ. Sargramostim for active Crohn's disease. New Engl J Med 2005; 352: 2193–201
   PubMed Web of Science ®Google Scholar
• Yang X, Liu F, Xu Z, Chen C, Wu X, Li G, et al. Expression of granulocyte colony stimulating factor receptor in human colorectal cancer. Postgrad Med J 2005; 81: 333–7
   PubMed Web of Science ®Google Scholar